Vident Investment Advisory, LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q1 2022$435,000
-11.9%
11,162
-9.9%
0.01%
-15.4%
Q4 2021$494,000
+7.6%
12,393
-2.4%
0.01%
-7.1%
Q3 2021$459,000
-6.5%
12,695
+29.4%
0.01%
-30.0%
Q4 2020$491,0009,8080.02%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2021
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders